247 related articles for article (PubMed ID: 18164930)
1. Increasing the oral bioavailability of the poorly water soluble drug itraconazole with ordered mesoporous silica.
Mellaerts R; Mols R; Jammaer JA; Aerts CA; Annaert P; Van Humbeeck J; Van den Mooter G; Augustijns P; Martens JA
Eur J Pharm Biopharm; 2008 May; 69(1):223-30. PubMed ID: 18164930
[TBL] [Abstract][Full Text] [Related]
2. Carboxylated mesoporous carbon microparticles as new approach to improve the oral bioavailability of poorly water-soluble carvedilol.
Zhang Y; Zhi Z; Li X; Gao J; Song Y
Int J Pharm; 2013 Sep; 454(1):403-11. PubMed ID: 23850816
[TBL] [Abstract][Full Text] [Related]
3. Mesoporous silica nanoparticles for increasing the oral bioavailability and permeation of poorly water soluble drugs.
Zhang Y; Wang J; Bai X; Jiang T; Zhang Q; Wang S
Mol Pharm; 2012 Mar; 9(3):505-13. PubMed ID: 22217205
[TBL] [Abstract][Full Text] [Related]
4. Physical state of poorly water soluble therapeutic molecules loaded into SBA-15 ordered mesoporous silica carriers: a case study with itraconazole and ibuprofen.
Mellaerts R; Jammaer JA; Van Speybroeck M; Chen H; Van Humbeeck J; Augustijns P; Van den Mooter G; Martens JA
Langmuir; 2008 Aug; 24(16):8651-9. PubMed ID: 18630936
[TBL] [Abstract][Full Text] [Related]
5. Ordered mesoporous silica induces pH-independent supersaturation of the basic low solubility compound itraconazole resulting in enhanced transepithelial transport.
Mellaerts R; Mols R; Kayaert P; Annaert P; Van Humbeeck J; Van den Mooter G; Martens JA; Augustijns P
Int J Pharm; 2008 Jun; 357(1-2):169-79. PubMed ID: 18325700
[TBL] [Abstract][Full Text] [Related]
6. Development of novel itraconazole-loaded solid dispersion without crystalline change with improved bioavailability.
Park YJ; Xuan JJ; Oh DH; Balakrishnan P; Yang HJ; Yeo WH; Lee MK; Choi HG; Yong CS
Arch Pharm Res; 2010 Aug; 33(8):1217-25. PubMed ID: 20803125
[TBL] [Abstract][Full Text] [Related]
7. Exploitation of 3D face-centered cubic mesoporous silica as a carrier for a poorly water soluble drug: influence of pore size on release rate.
Zhu W; Wan L; Zhang C; Gao Y; Zheng X; Jiang T; Wang S
Mater Sci Eng C Mater Biol Appl; 2014 Jan; 34():78-85. PubMed ID: 24268236
[TBL] [Abstract][Full Text] [Related]
8. Combined use of ordered mesoporous silica and precipitation inhibitors for improved oral absorption of the poorly soluble weak base itraconazole.
Van Speybroeck M; Mols R; Mellaerts R; Thi TD; Martens JA; Van Humbeeck J; Annaert P; Van den Mooter G; Augustijns P
Eur J Pharm Biopharm; 2010 Aug; 75(3):354-65. PubMed ID: 20420905
[TBL] [Abstract][Full Text] [Related]
9. Comparison of mesoporous silicon and non-ordered mesoporous silica materials as drug carriers for itraconazole.
Kinnari P; Mäkilä E; Heikkilä T; Salonen J; Hirvonen J; Santos HA
Int J Pharm; 2011 Jul; 414(1-2):148-56. PubMed ID: 21601623
[TBL] [Abstract][Full Text] [Related]
10. Biodegradable Porous Starch Spheres as a Novel Carrier for Enhancement of Dissolution Rate and Oral Bioavailability of Itraconazole.
Pawar J; Ali MT; Fule R; Moravkar K; Seervi M; Sathaye S; Amin P
Curr Drug Deliv; 2017; 14(7):944-954. PubMed ID: 27654575
[TBL] [Abstract][Full Text] [Related]
11. Impact of surface area of silica particles on dissolution rate and oral bioavailability of poorly water soluble drugs: a case study with aceclofenac.
Kumar D; Sailaja Chirravuri SV; Shastri NR
Int J Pharm; 2014 Jan; 461(1-2):459-68. PubMed ID: 24368106
[TBL] [Abstract][Full Text] [Related]
12. [Improving the dissolution rate of poorly water-soluble resveratrol by the ordered mesoporous silica].
Quan GL; Chen B; Wang ZH; Wu H; Huang XT; Wu LN; Wu CB
Yao Xue Xue Bao; 2012 Feb; 47(2):239-43. PubMed ID: 22512038
[TBL] [Abstract][Full Text] [Related]
13. In Vivo Performance of Fenofibrate Formulated With Ordered Mesoporous Silica Versus 2-Marketed Formulations: A Comparative Bioavailability Study in Beagle Dogs.
Bukara K; Schueller L; Rosier J; Daems T; Verheyden L; Eelen S; Martens JA; Van den Mooter G; Bugarski B; Kiekens F
J Pharm Sci; 2016 Aug; 105(8):2381-5. PubMed ID: 27364460
[TBL] [Abstract][Full Text] [Related]
14. Use of ordered mesoporous silica to enhance the oral bioavailability of ezetimibe in dogs.
Kiekens F; Eelen S; Verheyden L; Daems T; Martens J; Van Den Mooter G
J Pharm Sci; 2012 Mar; 101(3):1136-44. PubMed ID: 22190350
[TBL] [Abstract][Full Text] [Related]
15. Reduced food-effect and enhanced bioavailability of a self-microemulsifying formulation of itraconazole in healthy volunteers.
Woo JS; Song YK; Hong JY; Lim SJ; Kim CK
Eur J Pharm Sci; 2008 Feb; 33(2):159-65. PubMed ID: 18178070
[TBL] [Abstract][Full Text] [Related]
16. Preparation of silymarin proliposome: a new way to increase oral bioavailability of silymarin in beagle dogs.
Yan-yu X; Yun-mei S; Zhi-peng C; Qi-neng P
Int J Pharm; 2006 Aug; 319(1-2):162-8. PubMed ID: 16687221
[TBL] [Abstract][Full Text] [Related]
17. Ordered mesoporous silica to enhance the bioavailability of poorly water-soluble drugs: Proof of concept in man.
Bukara K; Schueller L; Rosier J; Martens MA; Daems T; Verheyden L; Eelen S; Van Speybroeck M; Libanati C; Martens JA; Van Den Mooter G; Frérart F; Jolling K; De Gieter M; Bugarski B; Kiekens F
Eur J Pharm Biopharm; 2016 Nov; 108():220-225. PubMed ID: 27648957
[TBL] [Abstract][Full Text] [Related]
18. Novel scheme for rapid synthesis of hollow mesoporous silica nanoparticles (HMSNs) and their application as an efficient delivery carrier for oral bioavailability improvement of poorly water-soluble BCS type II drugs.
Li T; Geng T; Md A; Banerjee P; Wang B
Colloids Surf B Biointerfaces; 2019 Apr; 176():185-193. PubMed ID: 30616109
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of dissolution rate and oral absorption of a poorly water-soluble drug, K-832, by adsorption onto porous silica using supercritical carbon dioxide.
Miura H; Kanebako M; Shirai H; Nakao H; Inagi T; Terada K
Eur J Pharm Biopharm; 2010 Oct; 76(2):215-21. PubMed ID: 20603215
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of novel core-shell structured dual-mesoporous silica nanospheres and their application for enhancing the dissolution rate of poorly water-soluble drugs.
Wu C; Sun X; Zhao Z; Zhao Y; Hao Y; Liu Y; Gao Y
Mater Sci Eng C Mater Biol Appl; 2014 Nov; 44():262-7. PubMed ID: 25280705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
